斑马鱼
生物
达尼奥
幼虫
药代动力学
体内
药理学
生态学
生物化学
生物技术
基因
作者
Vasudev Kantae,Elke H. J. Krekels,Anita Ordas,Oskar González,Rob Christiaan van Wijk,Amy C. Harms,Peter I. Racz,Piet H. van der Graaf,Herman P. Spaink,Thomas Hankemeier
出处
期刊:Zebrafish
[Mary Ann Liebert, Inc.]
日期:2016-09-15
卷期号:13 (6): 504-510
被引量:67
标识
DOI:10.1089/zeb.2016.1313
摘要
Abstract Zebrafish larvae ( Danio rerio ) are increasingly used to translate findings regarding drug efficacy and safety from in vitro -based assays to vertebrate species, including humans. However, the limited understanding of drug exposure in this species hampers its implementation in translational research. Using paracetamol as a paradigm compound, we present a novel method to characterize pharmacokinetic processes in zebrafish larvae, by combining sensitive bioanalytical methods and nonlinear mixed effects modeling. The developed method allowed quantification of paracetamol and its two major metabolites, paracetamol-sulfate and paracetamol-glucuronide in pooled samples of five lysed zebrafish larvae of 3 days post-fertilization. Paracetamol drug uptake was quantified to be 0.289 pmole/min and paracetamol clearance was quantified to be 1.7% of the total value of the larvae. With an average volume determined to be 0.290 μL, this yields an absolute clearance of 2.96 × 10 7 L/h, which scales reasonably well with clearance rates in higher vertebrates. The developed methodology will improve the success rate of drug screens in zebrafish larvae and the translation potential of findings, by allowing the establishment of accurate exposure profiles and thereby also the establishment of concentration–effect relationships.
科研通智能强力驱动
Strongly Powered by AbleSci AI